Investing.com -- The administration of U.S. President Joe Biden has determined that China employs unfair policies and practices to gain dominance in the global maritime, logistics, and shipbuilding ...

UK-exposed assets witnessed a significant sell-off on Friday, triggered by a confluence of spillovers from the US bond market and apprehensions regarding the UK’s economic growth and fiscal prospects.

With GBP positioning at neutral levels, BofA suggested a preference for observing signs of new shorts before re-entering into GBP longs. In contrast to the GBP, the Japanese yen (JPY) saw a positive ...

Shares of Establishment Labs Holdings Inc . (NASDAQ: NASDAQ: ESTA) tumbled 30% following the announcement that long-time CEO Juan José Chacón-Quirós is set to ...

Needham & Company analysts adjustmented their semiconductor capital equipment outlook in a note Monday, upgrading KLA Corp to Buy and naming Onto Innovation (NYSE:ONTO) as a top pick for 2025. The ...

ARS Pharmaceuticals’ stock experienced a significant rise, peaking at an 11% increase, marking the largest intraday leap since August. This surge was prompted by the company’s announcement of its ...

On Monday, Zevia PBC shares experienced a significant drop, plunging as much as 19% during intraday trading, marking the steepest decline since November 13.

Madrigal Pharmaceuticals, Inc. (NASDAQ: NASDAQ:MDGL) stock fell 11% following the company’s preliminary fourth-quarter and full-year 2024 financial performance announcement. Despite reporting net ...

Energy stocks saw an upward trend on Monday as oil prices increased due to the potential impact of new US sanctions on Russian oil supplies. These sanctions are expected to limit supplies from Russia, ...

Shares of BridgeBio Pharma, Inc. (NASDAQ: BBIO) surged today following the company’s announcement of latest updates on its late-stage pipeline programs. The bio ...

Alnylam Pharmaceuticals , Inc. (Nasdaq: NASDAQ: ALNY) stock rose 5.5% as the company announced preliminary fourth quarter and full-year 2024 revenue figures that ...

On Monday, shares of Standard BioTools saw a significant surge of 26% following the announcement of their preliminary fourth-quarter revenue. The company that merged with SomaLogic in the previous ...